Glide Pharma® is a pharmaceutical development and device company focused on the easy, safe and convenient administration of solid dose formulations of therapeutics and vaccines. The company has a range of in-house and partnered programmes based on its proprietary solid dose injector, the Glide SDI®. Glide Pharma has a strong management team with extensive experience of the pharmaceutical, biotechnology and medical device sectors. The company has successfully completed five investment rounds, and is supported by a consortium of institutional and private technology investors, including Invesco Perpetual, Oxford Technology Venture Capital Trusts, Oxford Capital Partners and Hygea VCT.
| Website | http://www.glidepharma.com |
| Revenue | $5.9 million |
| Funding | $58 million |
| Employees | View employees |
| Address | 45b Milton Park, Abingdon, Oxfordshire OX14 4RU, GB |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Roche, Medtronic, Novo Nordisk, AstraZeneca, BD, Insulet Corporation, Smiths Medical, Lilly India, Mylan Belgium, SYRIS Technology Corp +31 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Glide Pharma employee's phone or email?
Glide Pharma Questions
The Glide Pharma annual revenue was $5.9 million in 2026.
Glide Pharma is based in Abingdon, Oxfordshire.
The NAICS codes for Glide Pharma are [3254, 32, 325].
The SIC codes for Glide Pharma are [283, 28].
